Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_assertion type Assertion NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_head.
- NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_assertion description "[However, as GAGs inhibit OPG 1-401 but not OPG 1-194 binding to TRAIL or to RANKL, they may represent potent regulators of OPG availability and antitumor activity in bone tumor microenvironment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_provenance.
- NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_assertion evidence source_evidence_literature NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_provenance.
- NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_assertion SIO_000772 19147566 NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_provenance.
- NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_assertion wasDerivedFrom befree-20150227 NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_provenance.
- NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_assertion wasGeneratedBy ECO_0000203 NP602823.RApVr3oqT5iLfdT94V-LUJB_GFFcKBYYbYbeIhD73A7fE130_provenance.